FDC Ltd has entered into definitive documents (including a trademark assignment deed) on October 16, 2019 with GlaxoSmithKline Pharmaceuticals Limited (GSK) for acquiring the registered Trademark 'ENTEROPLUS' from GSK.
The transaction is subject to certain regulatory steps and upon completion thereof, the Company would have acquired all the rights of this Trademark/Brand 'ENTEROPLUS'.
Shares of FDC LTD. was last trading in BSE at Rs.162.45 as compared to the previous close of Rs. 159.35. The total number of shares traded during the day was 1089 in over 72 trades.
The stock hit an intraday high of Rs. 162.45 and intraday low of 159.65. The net turnover during the day was Rs. 175616.